| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $10.97M | -2,034 | |
| VP | 109.2K | $5.31M | - | |
| VP | 69.4K | $3.38M | -9,000 | |
| Dir | 43.3K | $2.11M | -44,472 | |
| CFO | 36.7K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2017 | Mitchell Paul J | Director | Sale+OE | 1,000 | $51.98 | $51,980.00 | -11.1% | |
| Nov 29, 2017 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sale+OE | 20,932 | $50.51 | $1,057,248.97 | -6.8% | |
| Nov 8, 2017 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sale+OE | 20,932 | $47.58 | $996,009.45 | -12.7% | |
| Nov 2, 2017 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $48.87 | $2,443,410.00 | -7.3% | |
| Nov 1, 2017 | Mitchell Paul J | Director | Sale+OE | 1,000 | $49.16 | $49,160.00 | -11.1% | |
| Nov 1, 2017 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 15,000 | $48.71 | $730,687.50 | -8.4% | |
| Oct 2, 2017 | Mitchell Paul J | Director | Sale+OE | 1,500 | $50.64 | $75,960.00 | -15.8% | |
| Sep 11, 2017 | Biberstein Kathryn L | Evp/ Cao/ CCO Alks Inc; Sec Alks | Sale+OE | 13,566 | $51.29 | $695,817.06 | -10.4% | |
| Sep 1, 2017 | Mitchell Paul J | Director | Sale+OE | 1,500 | $50.77 | $76,155.00 | -15.8% | |
| Aug 1, 2017 | Mitchell Paul J | Director | Sale+OE | 1,500 | $54.91 | $82,365.00 | -15.8% |